Rectal Epstein-Barr virus-positive Hodgkin's lymphoma in a patient with Crohn's disease: Case report and review of the literature

被引:27
作者
Bai, Maria
Katsanos, Konstantinos H.
Economou, Michael
Kamina, Sevasti
Balli, Christine
Briasoulis, Evangelos
Kappas, Angelos M.
Agnantis, Niki
Tsianos, Epameinondas V. [1 ]
机构
[1] Univ Ioannina, Sch Med, Dept Internal Med, Hepatogastroenterol Unit, GR-45110 Ioannina, Greece
[2] Univ Ioannina, Sch Med, Dept Pathol, GR-45110 Ioannina, Greece
[3] Univ Ioannina, Sch Med, Dept Surg, GR-45110 Ioannina, Greece
[4] Univ Ioannina, Sch Med, Dept Oncol, GR-45110 Ioannina, Greece
关键词
adenocarcinoma; Crohn's disease; Hodgkin's disease; inflammatory bowel disease; infliximab; lymphoma;
D O I
10.1080/00365520500529629
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We present the case of a 35-year-old man with Crohn's disease diagnosed at the age of 27, several months after an operation for small-bowel adenocarcinoma. Seven years after the adenocarcinoma diagnosis, the patient presented with severe continuous anal pain and diarrhea. In parallel with antibiotic administration, the patient was given treatment with Infliximab, but without clinical symptom amelioration. Sigmoidoscopy and subsequent biopsies from an ulcerated rectal area supported the diagnosis of Epstein-Barr virus-positive (EBV(+)) primary Hodgkin's lymphoma. Infliximab administration was immediately discontinued and the patient underwent oncological follow-up and began a course of chemotherapy. Only a few cases with primary gastrointestinal Hodgkin's lymphoma in Crohn's disease patients have so far been reported, including a variety of scenarios on the causal relationship including disease duration, presence of EBV, long-term immunosuppressive treatment and, recently, anti-TNF alpha administration.
引用
收藏
页码:866 / 869
页数:4
相关论文
共 31 条
[1]
DECREASED EXPRESSION OF CELLULAR MARKERS IN EPSTEIN-BARR VIRUS-POSITIVE HODGKINS-DISEASE [J].
BAI, MC ;
JIWA, NM ;
HORSTMAN, A ;
VOS, W ;
KLUIN, PH ;
VANDERVALK, P ;
MULLINK, H ;
WALBOOMERS, JMM ;
MEIJER, CJLM .
JOURNAL OF PATHOLOGY, 1994, 174 (01) :49-55
[2]
Tumor necrosis factor antagonist therapy and lymphoma development - Twenty-six cases reported to the Food and Drug Administration [J].
Brown, SL ;
Greene, MH ;
Gershon, SK ;
Edwards, ET ;
Braun, MM .
ARTHRITIS AND RHEUMATISM, 2002, 46 (12) :3151-3158
[3]
Christodoulou D, 2003, HEPATO-GASTROENTEROL, V50, P1021
[4]
Small bowel adenocarcinoma presenting as a first manifestation of Crohn's disease: report of a case, and a literature review [J].
Christodoulou, D ;
Skopelitou, AS ;
Katsanos, KH ;
Katsios, C ;
Agnantis, N ;
Price, A ;
Kappas, A ;
Tsianos, EV .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2002, 14 (07) :805-810
[5]
CODLING BW, 1977, SURGERY, V82, P625
[6]
COLLINS WJ, 1977, AM J GASTROENTEROL, V68, P177
[7]
LONG-TERM NEOPLASIA RISK AFTER AZATHIOPRINE TREATMENT IN INFLAMMATORY BOWEL-DISEASE [J].
CONNELL, WR ;
KAMM, MA ;
DICKSON, M ;
BALKWILL, AM ;
RITCHIE, JK ;
LENNARDJONES, JE .
LANCET, 1994, 343 (8908) :1249-1252
[8]
Cottone M, 2002, LANCET, V360, P1602, DOI 10.1016/S0140-6736(02)11538-8
[9]
EKBOM A, 1991, CANCER-AM CANCER SOC, V67, P2015, DOI 10.1002/1097-0142(19910401)67:7<2015::AID-CNCR2820670731>3.0.CO
[10]
2-R